News & Updates
Filter by Specialty:
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023
byElvira Manzano
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023ADHD meds emerge as preferred option for reducing self-harm risk in BPD
04 Jul 2023
byJairia Dela Cruz
For individuals with bipolar disorder (BPD), attention-deficit/hyperactive disorder (ADHD) medications help lower the risk of suicidal behaviour, according to data from a comparative effectiveness research study.
ADHD meds emerge as preferred option for reducing self-harm risk in BPD
04 Jul 2023Mood disorders affect one in ten ICD patients
04 Jul 2023
byKanas Chan
Depression, anxiety, and post-traumatic stress disorder (PTSD) are highly prevalent in patients with an implantable cardioverter defibrillator (ICD), a meta-analysis has revealed.